TOLAZINE
Live / Allowed — Second extension granted (statement of use) (as of 23 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Dec 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98930348
- Mark type
- Word mark
- Filed
- 31 Dec 2024
- Published for opposition
- 26 Aug 2025
- Attorney of record
- Harry B. Ray
Goods and services
- Class 005 — Pharmaceuticals: Veterinary pharmaceutical, namely, xylazine reversing agent and antagonist for use in horses
Owner
- Cronus Pharma LLC, East Brunswick, NJ, US
- Cronus Pharma LLC, East Brunswick, NJ, US
Prosecution history
- 24 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2026 — SOU EXTENSION 2 GRANTED
- 23 Jun 2026 — SOU EXTENSION 2 FILED
- 23 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Oct 2025 — SOU EXTENSION 1 GRANTED
- 21 Oct 2025 — SOU EXTENSION 1 FILED
- 21 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Aug 2025 — PUBLISHED FOR OPPOSITION
- 20 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Jul 2025 — ASSIGNED TO EXAMINER
- 31 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED